معرفی
Emily Collier is an Adjunct Assistant Professor in the Department of Medical Oncology and Hematology at Yale School of Medicine. She holds a joint appointment with the Center for Thoracic Cancers. Her clinical roles include serving as a Heme-Onc Medicine Fellow in Medical Oncology. She completed her MD at Harvard Medical School and a BS in Molecular Cellular and Developmental Biology at Yale University. Her research focuses on thoracic cancers, particularly lung cancer, with involvement in clinical trials evaluating novel therapies. Notable trials include studies on osimertinib and bevacizumab combinations for EGFR-mutant NSCLC and the LUNGMAP biomarker-driven therapy protocol.
- Education: BS (Yale, 2002), MD (Harvard, 2009), Internal Medicine Residency (Brigham and Women's Hospital, 2012)
- Research Interests: Investigating immunotherapies, targeted therapies, and biomarker-driven approaches in lung cancer. Recent work includes studies on innate immune system modulation in cancer response.
She contributes to translational research through Yale Cancer Center and the Center for Thoracic Cancers, aiming to advance treatment options for metastatic and recurrent malignancies.
